Pregnenolone Carbonitrile
CAS No. 1434-54-4
Pregnenolone Carbonitrile ( 5-Pregnen-3β-ol-20-one-16α-carbonitrile | Pregnenolone 16α-carbonitrile? )
产品货号. M27472 CAS No. 1434-54-4
Pregnenolone Carbonitrile 是啮齿动物 PXR 的激活剂,可诱导 CYP3A 的表达。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥316 | 有现货 |
|
| 5MG | ¥518 | 有现货 |
|
| 10MG | ¥786 | 有现货 |
|
| 25MG | ¥1369 | 有现货 |
|
| 50MG | ¥2017 | 有现货 |
|
| 100MG | ¥3021 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Pregnenolone Carbonitrile
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Pregnenolone Carbonitrile 是啮齿动物 PXR 的激活剂,可诱导 CYP3A 的表达。
-
产品描述Pregnenolone Carbonitrile is an activator of rodent-PXR and induces the expression of CYP3A.(In Vitro):Pregnenolone Carbonitrile is hepatoprotective by increasing resistance to subsequent stressful insults.(In Vivo):In WT mice, Pregnenolone Carbonitrile (40 mg/kg/day; i.p.) induces the expression of CYP3A11 and CYP2B10 at the mRNA, protein, and enzymatic levels. In adult female Sprague-Dawley rats, Pregnenolone Carbonitrile (100 mg/kg; i.p.) induces the expression of CYP3A mRNA. In male Sprague-Dawley rats, Pregnenolone Carbonitrile (35 mg/kg; gavage) increase in Pgp expression.
-
体外实验——
-
体内实验Animal Model:WT and Pxr-/- mice Dosage:40 mg/kg Administration:IP; per day for two days Result:Induced the expression of Cyp3a11 and Cyp2b10 at the mRNA, protein, and enzymatic levels in WT mice.Had little effect on the expression of Cyp3a11 in Pxr-/- mice
-
同义词5-Pregnen-3β-ol-20-one-16α-carbonitrile | Pregnenolone 16α-carbonitrile?
-
通路Metabolic Enzyme/Protease
-
靶点P450
-
受体enoyl-acyl carrier protein reductase (FabI)|S. aureus
-
研究领域——
-
适应症——
化学信息
-
CAS Number1434-54-4
-
分子量341.49
-
分子式C22H31NO2
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 20 mg/mL (58.57 mM)
-
SMILESC[C@@]12[C@]([C@]3([C@](CC1)([C@]4(C)C(=CC3)C[C@@H](O)CC4)[H])[H])(C[C@@H](C#N)[C@@H]2C(C)=O)[H]
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Kim BY, Sohn YT. Solid state of CG-400549, a novel FabI inhibitor: characterization, dissolution, transformation. Arch Pharm Res. 2011 May;34(5):775-9.
021-51111890
购物车()
sales@molnova.cn

